GC
MRK icon

Gibson Capital’s Merck MRK Stock Holding History

Gibson Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$326K Sell
2,709
-1
-0% -$115 0.06% 66
2025
Q4 		$285K Sell
2,710
-570
-17% -$53.5K 0.05% 67
2025
Q3 		$275K Sell
3,280
-7
-0.2% -$577 0.05% 73
2025
Q2 		$260K Sell
3,287
-192
-6% -$15.3K 0.05% 70
2025
Q1 		$312K Buy
3,479
+190
+6% +$17.7K 0.07% 57
2024
Q4 		$327K Buy
3,289
+9
+0.3% +$928 0.07% 46
2024
Q3 		$372K Hold
3,280
– – 0.08% 43
2024
Q2 		$406K Buy
3,280
+50
+2% +$6.44K 0.09% 38
2024
Q1 		$426K Hold
3,230
– – 0.09% 39
2023
Q4 		$352K Buy
3,230
+33
+1% +$3.42K 0.08% 43
2023
Q3 		$329K Hold
3,197
– – 0.09% 34
2023
Q2 		$369K Buy
3,197
+18
+0.6% +$2.04K 0.1% 32
2023
Q1 		$338K Hold
3,179
– – 0.09% 33
2022
Q4 		$353K Hold
3,179
– – 0.11% 29
2022
Q3 		$275K Sell
3,179
-261
-8% -$23.3K 0.09% 32
2022
Q2 		$310K Buy
+3,440
New +$305K 0.09% 30

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gibson Capital's MRK Position: Q1 2026 in Review

Gibson Capital reduced its Merck (MRK) stake by 0.04% in Q1 2026, selling an estimated $115 and leaving 2,709 shares worth $326K. The position accounts for 0.06% of the portfolio, ranked #66.

Gibson Capital first reported a position in MRK in Q2 2022 and has held it in 16 quarters since. The position peaked at $426K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Gibson Capital held 2,709 shares of Merck worth $326K as of Q1 2026.
  • Gibson Capital sold 1 Merck share in Q1 2026, an estimated $115.
  • Merck made up 0.06% of Gibson Capital's portfolio in Q1 2026, its #66 holding.
  • Gibson Capital first reported a position in Merck in Q2 2022 and has held it in 16 quarters since.
  • Gibson Capital's Merck position peaked at $426K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Gibson Capital's 13F filing for Q1 2026, filed 17 Apr 2026.